5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.25%
Revenue growth similar to METSB.HE's 12.25%. Walter Schloss would see if both companies share industry tailwinds.
44.98%
Gross profit growth similar to METSB.HE's 44.98%. Walter Schloss would assume both firms track common industry trends.
21.04%
EBIT growth similar to METSB.HE's 21.04%. Walter Schloss might infer both firms share similar operational efficiencies.
21.04%
Operating income growth similar to METSB.HE's 21.04%. Walter Schloss would assume both share comparable operational structures.
60.67%
Net income growth comparable to METSB.HE's 60.67%. Walter Schloss might see both following similar market or cost trajectories.
63.16%
EPS growth similar to METSB.HE's 63.16%. Walter Schloss would assume both have parallel share structures and profit trends.
63.16%
Similar diluted EPS growth to METSB.HE's 63.16%. Walter Schloss might see standard sector or cyclical influences on both firms.
No Data
No Data available this quarter, please select a different quarter.
-1.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-22.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-8.68%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
25.96%
5Y revenue/share CAGR similar to METSB.HE's 25.96%. Walter Schloss might see both companies benefiting from the same mid-term trends.
17.83%
3Y revenue/share CAGR similar to METSB.HE's 17.83%. Walter Schloss would assume both companies experience comparable short-term cycles.
182.79%
10Y OCF/share CAGR in line with METSB.HE's 182.79%. Walter Schloss would see both as similarly efficient over the decade.
247.97%
5Y OCF/share CAGR is similar to METSB.HE's 247.97%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
150.87%
3Y OCF/share CAGR similar to METSB.HE's 150.87%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
731.07%
Similar net income/share CAGR to METSB.HE's 731.07%. Walter Schloss would see parallel tailwinds or expansions for both firms.
211.38%
5Y net income/share CAGR similar to METSB.HE's 211.38%. Walter Schloss might see both on parallel mid-term trajectories.
83.17%
3Y net income/share CAGR similar to METSB.HE's 83.17%. Walter Schloss would attribute it to shared growth factors or demand patterns.
99.05%
10Y equity/share CAGR in line with METSB.HE's 99.05%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
57.70%
5Y equity/share CAGR is in line with METSB.HE's 57.70%. Walter Schloss would see parallel mid-term profitability and retention policies.
31.43%
3Y equity/share CAGR similar to METSB.HE's 31.43%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.89%
AR growth well above METSB.HE's 30.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.56%
Inventory growth well above METSB.HE's 10.56%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.44%
Similar asset growth to METSB.HE's 6.44%. Walter Schloss finds parallel expansions or investment rates.
0.10%
Similar to METSB.HE's 0.10%. Walter Schloss finds parallel capital usage or profit distribution strategies.
4.68%
Debt growth far above METSB.HE's 4.68%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.